Chronic Obstructive Pulmonary Disease
Conditions
Interventions
Experimental Group:Yi Huo Hua Tan granule
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
45 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Diagnosis of stable COPD according to western medicine; (2) Diagnosis of qi deficiency syndrome with phlegm and blood stasis obstructing the lung according to TCM; (3) Aged between 45 and 80 years old; (4) Signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Chronic cough and wheeze caused by tuberculosis, tumour, irritant gas or anaphylactic reaction; (2) Patients with serious primary diseases of cardiovascular, liver, kidney and hematopoietic system; (3) Chronic bronchitis complicated with acute cardiac insufficiency; (4) Behavior or mental illness; (5) Allergic constitution; (6) patients who can not use the drug according the plan or whose information in not complicated; (7) Participanting in other drug clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of exacerbations in last 12 months; | — |
Secondary
| Measure | Time frame |
|---|---|
| CAT;mMRC;CCQ;6MWT;SGRQ;HADS;Lung function test;TCM score;Plasma inflammation cytokines;Induced sputum inflammation cytokines; | — |
Countries
China
Contacts
Public ContactBing Mao
West China Hospital of Sichuan University
Outcome results
None listed